Loading...

The Oncology Institute, Inc.

TOINASDAQ
HealthcareMedical - Care Facilities
$2.99
$-0.05(-1.64%)

The Oncology Institute, Inc. (TOI) Stock Overview

Explore The Oncology Institute, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
21.33%
21.33%
Profit Growth
$-0.09
22.16%
EPS Growth
$-0.09
99.89%
Operating Margin
-12.91%
21.94%
ROE
-509.70%
22.16%
Dividend Yield
0.00%
Analyst Recommendations data is not available for TOIAnalyst Recommendations details for TOI are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.

CEO

Dr. Daniel Virnich FACHE, M.B.A., M.D.

Employees

825

Headquarters

18000 Studebaker Road, Cerritos, CA

Founded

2020

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.